Gain Therapeutics Inc. (GANX)
undefined
undefined%
At close: undefined
1.50
-7.98%
Pre-market Dec 16, 2024, 04:03 AM EST

Gain Therapeutics Inc. Forcast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for GANX stock have an median target of 7.5, with a low estimate of 6 and a high estimate of 8. The median target predicts an increase of 360.12% from the current stock price of 1.63.

Analyst Consensus: Buy
Target Low Average Median High
Price $6 $7.25 $7.5 $8
Change 268.10% 344.79% 360.12% 390.80%

AI Analyst Report

HC Wainwright & Co. has reaffirmed a Buy rating on... Unlock content with Pro Subscription

Updated Nov 25, 2024

Rating Jul 24Aug 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 000000
Buy 221211
Hold 000000
Sell 000000
Strong Sell 000000
Total 2 2 1 2 1 1

Financial Forecast this Year

Revenue This Year
20.00K
from 55.18K
Increased by -63.8%
Revenue Next Year
100.00K
from 20.00K
Increased by 400.0%
EPS This Year
-1.04
from -1.71
Increased by 39.2%
EPS Next Year
-0.91
from -1.04
Increased by 12.5%